Sabrina Herlo

Pharma organizations can spend as much as $4.54B to bring a single molecule to market. The costs are only rising, while regulations are becoming more complex. This pressures organizations to manage extensive portfolios and afferent regulatory dossiers with fewer resources. When regulatory submissions take too long or are not accepted, organizations incur significant costs, from […]